Physician profile
Martin Kent
NPI 1396387122
$1,962.56
in general payments reported to CMS, 2019-2025
18 companies · $439 in 2025
The $439 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $234 · 2022: $96.17 · 2023: $635 · 2024: $558 · 2025: $439.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,632.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $920.54 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $177.36 | 2023-2025 | |
| Cvrx, INC. | $156.39 | 2024 | Barostim Neo System |
| Boston Scientific Corporation | $153.77 | 2023 | Watchman Access System |
| Medtronic, INC. | $147.36 | 2023 | Micra, Linq II |
| Kestra Medical Technology Services, INC. | $123.87 | 2023-2024 | Assure Wcd |
| Pfizer INC. | $33.81 | 2024 | |
| Philips North America LLC | $27.50 | 2025 | Diagnostic Ecg Service |
| Janssen Pharmaceuticals, INC | $27.20 | 2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $27.02 | 2024 | Amvuttra |
| Heartflow, INC. | $26.11 | 2025 | |
| Inspire Medical Systems, INC. | $23.85 | 2025 | Inspire |
| Actelion Pharmaceuticals US, INC. | $23.56 | 2025 | Opsynvi |
| Novo Nordisk INC | $19.94 | 2024 | Rybelsus, Ozempic |
| Biosense Webster, INC. | $19.70 | 2025 | Nuvision Ice Catheter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $19.34 | 2024 | Optimizer |
| Merck Sharp & Dohme LLC | $18.63 | 2022 | |
| Abiomed | $16.61 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Kent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.